ERYTHROMYCIN - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for erythromycin and what is the scope of patent protection?
Erythromycin
is the generic ingredient in fifty-two branded drugs marketed by Dr Reddys Labs Sa, Parke Davis, Warner Chilcott Llc, Hospira, Azurity, Barr, Mylan, Altana, Encube, Fougera Pharms, Padagis Us, Syosset, Bausch And Lomb, Pharmaderm, Pharmafair, Sentiss, Dista, Bausch, Paddock Llc, Taro, Arbor Pharms Inc, Merz Pharms, Micro Labs, Epic Pharma Llc, Alpharma Us Pharms, Lilly, Pai Holdings Pharm, Pharmobedient Cnsltg, Renaissance Pharma, Dow Pharm, Westwood Squibb, Ivax Sub Teva Pharms, Johnson And Johnson, Amneal Pharms Co, Torrent, Solvay, Robins Ah, Alembic, Alkem Labs Ltd, Cadila Pharms Ltd, Teva Pharms Usa Inc, Zydus Lifesciences, Zydus Pharms, Watson Labs, Cosette, Life Labs, Amneal Pharms, Ani Pharms, Par Pharm Inc, Ross Labs, Pharmacia And Upjohn, Arbor Pharms Llc, Naska, Wyeth Ayerst, Aurobindo Pharma Usa, Alra, Abbott, Elkins Sinn, Abraxis Pharm, Baxter Hlthcare, Exela Pharma, Nexus, Teva Parenteral, Bristol, Warner Chilcott, Lederle, Purepac Pharm, Bristol Myers Squibb, and Pfizer, and is included in one hundred and thirty-eight NDAs. Additional information is available in the individual branded drug profile pages.There are one hundred and three drug master file entries for erythromycin. Thirty-three suppliers are listed for this compound.
Summary for ERYTHROMYCIN
US Patents: | 0 |
Tradenames: | 52 |
Applicants: | 69 |
NDAs: | 138 |
Drug Master File Entries: | 103 |
Finished Product Suppliers / Packagers: | 33 |
Raw Ingredient (Bulk) Api Vendors: | 103 |
Clinical Trials: | 136 |
Patent Applications: | 6,975 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price trends for ERYTHROMYCIN |
Drug Sales Revenues: | Drug sales revenues for ERYTHROMYCIN |
What excipients (inactive ingredients) are in ERYTHROMYCIN? | ERYTHROMYCIN excipients list |
DailyMed Link: | ERYTHROMYCIN at DailyMed |
Recent Clinical Trials for ERYTHROMYCIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Takeda | Phase 1 |
Chang Gung Memorial Hospital | Phase 1/Phase 2 |
Assiut University | N/A |
Pharmacology for ERYTHROMYCIN
Drug Class | Macrolide Antimicrobial Macrolide |
Physiological Effect | Decreased Sebaceous Gland Activity |
Medical Subject Heading (MeSH) Categories for ERYTHROMYCIN
Anatomical Therapeutic Chemical (ATC) Classes for ERYTHROMYCIN
US Patents and Regulatory Information for ERYTHROMYCIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amneal Pharms | ERYTHROMYCIN ETHYLSUCCINATE | erythromycin ethylsuccinate | GRANULE;ORAL | 211204-001 | Nov 1, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Barr | E-BASE | erythromycin | TABLET, DELAYED RELEASE;ORAL | 063028-001 | May 15, 1990 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Alpharma Us Pharms | ERYTHROMYCIN ETHYLSUCCINATE | erythromycin ethylsuccinate | SUSPENSION;ORAL | 062200-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Lederle | ERYTHROMYCIN STEARATE | erythromycin stearate | TABLET;ORAL | 062089-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Azurity | E.E.S. | erythromycin ethylsuccinate | TABLET, CHEWABLE;ORAL | 050297-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Azurity | ERYPED | erythromycin ethylsuccinate | GRANULE;ORAL | 050207-003 | Mar 30, 1987 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Amneal Pharms Co | ERYTHROMYCIN | erythromycin | TABLET;ORAL | 209720-001 | Mar 9, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.